Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Diane Seimetz

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 10, 2014
The role of relative lymphocyte count as a biomarker for the effect of catumaxomab on survival in malignant ascites patients: results from a phase II/III studyMarkus M Heiss, Michael A Ströhlein, Carsten Bokemeyer, et al.
Journal of Wound Care|June 15, 2018
Advanced therapies in wound management: cell and tissue based therapies, physical and bio-physical therapies smart and IT based technologiesAlberto Piaggesi, Severin Låuchli, Franco Bassetto, et al.
Human Vaccines & Immunotherapeutics|August 20, 2013
The trifunctional antibody catumaxomab amplifies and shapes tumor-specific immunity when applied to gastric cancer patients in the adjuvant settingDjordje Atanackovic, Henrike Reinhard, Sabrina Meyer, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 10, 2014
The role of relative lymphocyte count as a biomarker for the effect of catumaxomab on survival in malignant ascites patients: results from a phase II/III studyMarkus M Heiss, Michael A Ströhlein, Carsten Bokemeyer, et al.
Journal of Wound Care|June 15, 2018
Advanced therapies in wound management: cell and tissue based therapies, physical and bio-physical therapies smart and IT based technologiesAlberto Piaggesi, Severin Låuchli, Franco Bassetto, et al.
Human Vaccines & Immunotherapeutics|August 20, 2013
The trifunctional antibody catumaxomab amplifies and shapes tumor-specific immunity when applied to gastric cancer patients in the adjuvant settingDjordje Atanackovic, Henrike Reinhard, Sabrina Meyer, et al.
Pageof 2